SLC15A1 and hepatocellular carcinoma: reported that PEPT1 expression is elevated in HCC cell lines and tissues, which could improve anti‐tumor efficacy by increasing the cellular accumulation of a tripeptide conjugated to doxorubicin.[22, 23] However, no studies have clarified the role of PEPT1 and its clinical significance in HCC metastasis.